
Rylo Health review
Three prices, one product
$149 standard, $349 quarterly, and a $100 “first 20 patients” rate — three figures for the same semaglutide.
Our verdict
Rylo publishes all three, which is the right behavior. The promotional one still deserves reading carefully: a rate capped at the first twenty patients is a launch mechanic rather than a price, and nothing on the page says whether those twenty are gone. Plan on $149. The quarterly at $349 does work out below the monthly rate, so it is a real saving rather than a rounding of one.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- compounded semaglutide
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- Availability
- 50 states
- Updated
- September 2026
What it is
A fifty-state telehealth service prescribing compounded semaglutide and tirzepatide by weekly injection, on monthly or quarterly billing.
How it works
Prescription-gated telehealth with a monthly standard rate and a quarterly alternative, plus a capped promotional tier for early patients.
Pricing transparency
Semaglutide: $149 standard monthly, $349 quarterly, with a $100 rate advertised for the first twenty patients. Tirzepatide: $249 standard, $499 quarterly, with a $160 first-twenty rate. Both hold across every dose.
Branded vs compounded
Compounded semaglutide and tirzepatide. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing.
Pros and watch-outs
What we like
- All three figures are published, including the standard rate
- Flat across the dose ladder on both molecules
- $149 semaglutide is below the middle of the field
- Fifty states
Watch-outs
- The promotional rate is capped at twenty patients with no counter
- The quarterly rate works out above the monthly one
- $100 step to tirzepatide is toward the wide end
- Injection only
Best for
Buyers comparing on the standard rate and treating the promotion as a bonus.
Who should look elsewhere
Anyone choosing on the $100 figure, which may already be unavailable.
How Rylo Health compares
A few alternatives worth a look, depending on what you’re optimizing for.
- Oak
Flat dose pricing without a subscription
See Oak → - Synergy Rx
Both molecules in both forms
See Synergy Rx → - Care Bare Rx
A single entry price, if you are starting on semaglutide
See Care Bare Rx →
More compounded semaglutide sellers reviews: Revive MedsRewinding RXRivo HealthThe EditTMatesTrellis Vitality
Editor · Reviewed and last verified September 2026
How we assessed this. This review reflects GLP Loss’s own read of Rylo Health’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Can I get Rylo Health for $100 a month?
- Only as one of the first twenty patients, and the site gives no way to tell how many remain. Treat $149 as the price and the promotion as something to ask about, not to budget on.
- Is the quarterly plan cheaper at Rylo?
- No. $349 a quarter works out to about $116 a month — which is below the monthly rate for semaglutide, so the quarterly is the better deal there. For tirzepatide, $499 a quarter against $249 monthly is a larger saving still. Confirm the term at checkout before assuming either.
- Does the price rise with the dose?
- No. Both molecules hold one price at every dose.
- What does tirzepatide cost?
- $249 a month standard, or $499 quarterly. The $100 step from semaglutide is toward the wide end of this market, where gaps run from nothing to double.
- Is Rylo Health legit?
- Rylo Health is a compounded semaglutide sellers service. Its stated availability: 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Rylo Health expensive compared with other compounded semaglutide sellers providers?
- Rylo Health publishes a starting figure of $149/mo. Across the 59 compounded semaglutide sellers providers we review that publish a single monthly figure, those run $79 to $369 with a median of $150, which puts Rylo Health below the median, toward the cheaper end. The other 1 compounded semaglutide sellers providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.